Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Details 3)

v3.20.1
Shareholders' Deficit (Details 3) - Warrants [Member]
12 Months Ended
Dec. 31, 2019
USD ($)
$ / shares
shares
Number of Warrants  
Balance Outstanding, Beginning
Granted 2,050,000
Cancelled
Balance Outstanding, Ending 2,050,000
Exercisable 2,050,000
Weighted Average Exercise Price  
Balance Outstanding, Beginning | $ / shares
Granted | $ / shares 0.10
Cancelled | $ / shares
Balance Outstanding, Ending | $ / shares $ 0.10
Weighted Average Remaining Contractual Term (Years)  
Balance Outstanding, Ending 4 years 7 months 28 days
Exercisable 4 years 7 months 28 days
Aggregate Intrinsic Value  
Balance Outstanding, Ending | $ $ 4,400
Exercisable | $ $ 4,400